Your English writing platform
Discover LudwigSuggestions(3)
Exact(11)
Mucosal vaccine with protein antigens is a very promising product format for future vaccine development, especially considering the desired immunity protection at the mucosal surface and the safety of protein antigens.
However, the efficacy of more recently developed vaccines is limited by antigen variation, which also presents a challenge for future vaccine development.
These data may be very valuable for future vaccine development.
The consequences of these findings for future vaccine development are discussed.
The NS-2 deletion is a cornerstone for future vaccine development.
This variability poses a challenge for future vaccine development that relies on worldwide molecular epidemiologic studies.
Similar(49)
Adoptive transfer of lymphocyte subpopulations from vaccinated donors into SIV-naïve animals may define the immune mechanisms responsible for protection and guide future vaccine development.
Accurate epidemiological data on HPV prevalence and genotypes in specific populations will assist public health authorities to plan for immunization implementation, and to guide future vaccine development.
Highly engineered vaccines including vaccines for conditions other than infectious diseases are expected to dominate future vaccine development.
That observation could inform future vaccine development, he says.
Future vaccine developments for adults are likely to be based on conjugate-polysaccharides and we believe that differences in serotype-specific mortality could be important to consider when including capsular serotypes.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com